Literature DB >> 29793994

Response by Cui et al to Letter Regarding Article, "RGC-32 (Response Gene to Complement 32) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis".

Xiao-Bing Cui1, Jun-Na Luan1, Kun Dong1, Sisi Chen1, Yongyi Wang2, Wendy T Watford3, Shi-You Chen1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29793994      PMCID： PMC5975391          DOI： 10.1161/ATVBAHA.118.311146

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  10 in total

1.  Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration.

Authors:  Jia-Ning Wang; Ning Shi; Wei-Bing Xie; Xia Guo; Shi-You Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-02       Impact factor: 8.311

2.  RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase.

Authors:  Tudor Badea; Florin Niculescu; Lucian Soane; Matthew Fosbrink; Hila Sorana; Violeta Rus; Moon L Shin; Horea Rus
Journal:  J Biol Chem       Date:  2001-10-30       Impact factor: 5.157

3.  RGC32 Promotes Bleomycin-Induced Systemic Sclerosis in a Murine Disease Model by Modulating Classically Activated Macrophage Function.

Authors:  Chenming Sun; Shi-You Chen
Journal:  J Immunol       Date:  2018-03-05       Impact factor: 5.422

Review 4.  Macrophage functions in atherosclerosis.

Authors:  Iris Zeller; Sanjay Srivastava
Journal:  Circ Res       Date:  2014-12-05       Impact factor: 17.367

5.  RGC-32 is a novel regulator of the T-lymphocyte cell cycle.

Authors:  Cosmin A Tegla; Cornelia D Cudrici; Vinh Nguyen; Jacob Danoff; Adam M Kruszewski; Dallas Boodhoo; Armugam P Mekala; Sonia I Vlaicu; Ching Chen; Violeta Rus; Tudor C Badea; Horea Rus
Journal:  Exp Mol Pathol       Date:  2015-03-11       Impact factor: 3.362

Review 6.  Macrophages in the pathogenesis of atherosclerosis.

Authors:  Kathryn J Moore; Ira Tabas
Journal:  Cell       Date:  2011-04-29       Impact factor: 41.582

7.  RGC-32 is expressed in the human atherosclerotic arterial wall: Role in C5b-9-induced cell proliferation and migration.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Dallas Boodhoo; Takahiro Ito; Matthew Fosbrink; Cornelia Cudrici; Armugam P Mekala; Jonathan Ciriello; Doiniţa Crişan; Emil Boţan; Violeta Rus; Horea Rus
Journal:  Exp Mol Pathol       Date:  2016-09-13       Impact factor: 3.362

8.  Response gene to complement 32 protein promotes macrophage phagocytosis via activation of protein kinase C pathway.

Authors:  Rui Tang; Gui Zhang; Shi-You Chen
Journal:  J Biol Chem       Date:  2014-06-27       Impact factor: 5.157

9.  KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis.

Authors:  Laura S Shankman; Delphine Gomez; Olga A Cherepanova; Morgan Salmon; Gabriel F Alencar; Ryan M Haskins; Pamela Swiatlowska; Alexandra A C Newman; Elizabeth S Greene; Adam C Straub; Brant Isakson; Gwendalyn J Randolph; Gary K Owens
Journal:  Nat Med       Date:  2015-05-18       Impact factor: 53.440

10.  RGC-32 (Response Gene to Complement 32) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis.

Authors:  Xiao-Bing Cui; Jun-Na Luan; Kun Dong; Sisi Chen; Yongyi Wang; Wendy T Watford; Shi-You Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-15       Impact factor: 8.311
  10 in total
  1 in total

1.  Puerarin Attenuates LPS-Induced Inflammatory Responses and Oxidative Stress Injury in Human Umbilical Vein Endothelial Cells through Mitochondrial Quality Control.

Authors:  Xing Chang; Tian Zhang; Dong Liu; Qingyan Meng; Peizheng Yan; Duosheng Luo; Xue Wang; XiuTeng Zhou
Journal:  Oxid Med Cell Longev       Date:  2021-02-27       Impact factor: 6.543
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.